G 343 (Oxybutynin chloride extended release 15 mg)

Pill imprint G 343 has been identified as Oxybutynin chloride extended release 15 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G 343

Oxybutynin chloride extended release 15 mg G 343
Oxybutynin chloride extended release 15 mg G 343
Oxybutynin chloride extended release 15 mg G 343
Oxybutynin chloride extended release
Imprint:
G 343
Strength:
15 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5208
Inactive Ingredients:
hypromelloses
lactose monohydrate
methacrylic acid
microcrystalline cellulose
magnesium silicate
triethyl citrate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5743 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)